Project Description: Two-story R&D building

Building Size: ± 100,000 square feet

Built by: Stanford Real Estate

Tenant: Jazz Pharmaceuticals

Completion: February 2019

This project is a redevelopment of three existing R&D buildings that had reached the end of their useful lives. Stanford Real Estate began the redevelopment process of the properties in 2016.

In September 2017, Jazz Pharmaceuticals, a Dublin, Ireland based biopharmaceutical company, leased the upcoming building. Jazz develops and commercializes pharmaceutical products to address medical needs in the therapeutic areas of narcolepsy, oncology, pain and psychiatry. Tenants in the Stanford Research Park since 2004, Jazz now occupies two proximate buildings on Porter Drive.